Skip to main content
Peter Simpson, MD, Gastroenterology, Mountain View, CA, El Camino Health

PeterWilliamSimpsonMD

Gastroenterology Mountain View, CA

Physician

Are you Dr. Simpson?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 62 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Peter Simpson, MD is a gastroenterologist in Mountain View, California. He is currently licensed to practice medicine in California. He is affiliated with El Camino Health, Good Samaritan Hospital, and Mills-Peninsula Medical Center.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 2003 - 2006
  • St Mary's Hospital and Medical Center
    St Mary's Hospital and Medical CenterResidency, Internal Medicine, 2001 - 2002
  • University of California, Davis, School of Medicine
    University of California, Davis, School of MedicineClass of 1998

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2000 - 2025
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Press Mentions

  • Complex Medicines: A Multi-Billion Pound Addition to UK Industry
    Complex Medicines: A Multi-Billion Pound Addition to UK IndustryJuly 19th, 2021
  • Alchemab and Medicines Discovery Catapult to Develop Landmark Novel Antibody Therapy for Huntington’s Disease
    Alchemab and Medicines Discovery Catapult to Develop Landmark Novel Antibody Therapy for Huntington’s DiseaseMarch 16th, 2021
  • UK Innovators Target Nanoparticles at Inoperable Cancers
    UK Innovators Target Nanoparticles at Inoperable CancersDecember 18th, 2020
  • Join now to see all

Hospital Affiliations